How NBT is better at providing accurate cancer diagnosis

Cancers cells now have a powerful adversary called ‘magnetic hyperthermia’ and it consists of clusters of magnetic nanoparticles. The experimental new method uses magnetic nanoparticles, injected directly into a tumor with a syringe and by using alternating magnetic current, the particles heat up and ‘cook’ the tumor.

Magnetic nanoparticles show great promise in clinical trials on patients with brain and prostate cancers. However, a powerful new treatment can only be as effective as the diagnosis proceeding it. Like a hunter wearing a blindfold, a technique hamstrung if it cannot aim or hit the target. Therefore if a patient is misdiagnosed, the following treatment can only be effective in cooking the wrong cells. Furthermore,  even the most powerful anti-tumour therapies will struggle in cases where a diagnosis comes too late, once the cancers have spread to areas that can be very risky to insert a syringe.

As current diagnostic tools often rely on human analysis and interpretation, misdiagnoses and late diagnoses are all too common. Leading diagnostic technology company, ANCON Medical, comments on the reasons why an early and accurate diagnosis is key to getting the most out of a promising new treatment

Read more: https://www.news-medical.net/news/20190701/ANCON-Medical-discusses-how-NBT-technology-is-better-at-providing-accurate-cancer-diagnosis.aspx

Read previous article

Search news

Categorized news

Read from archive

Be the first to get our news

NBT Technology Video